Skip to main content
. 2013 Jun 12;143(8):1340–1347. doi: 10.3945/jn.113.174383

TABLE 3.

Adipose tissue expression of genes encoding mediators of inflammation in overweight to moderately obese men and women before and after 14 wk of consuming a diet rich in n3 PUFAs vs. a control diet low in n3 PUFAs1

mRNA copies
P value (RM-ANOVA)
Post lead-in period (CRC1) Post ad libitum period (CRC3) Time Time × treatment Time × weight change
n/ng total mRNA
TNFα
 Control 7.99 (7.14, 9.39) 8.70 (7.33, 9.32) 0.91 0.70 0.42
 n3 PUFA 7.75 (6.99, 9.87) 8.87 (7.58, 12.2)
IL6
 Control 23.3 (22.1, 34.1) 26.4 (16.9, 37.3) 0.11 0.10 0.79
 n3 PUFA 24.1 (20.6, 56.1) 20.6 (14.5, 24.8)
CD14
 Control 256 ± 52.5 277 ± 85.1 0.21 0.96 0.42
 n3 PUFA 296 ± 76.5 317 ± 92.3
CCL2
 Control 2520 (2180, 3030) 2370 (1930, 5230) 0.19 0.95 0.72
 n3 PUFA 2230 (1410, 2600) 2220 (1990, 2870)
ADIPOQ
 Control 7310 ± 1800 6950 ± 1960 0.38 0.89 0.04
 n3 PUFA 7630 ± 1340 7470 ± 1870
ICAM1
 Control 55.7 (49.4, 62.8) 58.9 (49.7, 67.1) 0.90 0.61 0.87
 n3 PUFA 61.6 (52.5, 66.5) 58.2 (44.5, 59.5)
SAA1
 Control 17,400 ± 8660 14,400 ± 9060 0.81 0.59 0.05
 n3 PUFA 15,500 ± 7590 14,400 ± 9470
CD206
 Control 214 ± 53.4 226 ± 53.4 0.82 0.64 0.59
 n3 PUFA 248 ± 30.1 251 ± 51.7
CD284
 Control 161 ± 27.6 167 ± 21.1 0.27 0.30 0.21
 n3 PUFA 165 ± 40.4 155 ± 39.6
PAI-1
 Control 14.2 (6.88, 20.4) 13.4 (10.9, 16.5) 0.97 0.30 0.14
 n3 PUFA 15.6 (7.35, 19.5) 12.1 (6.41, 32.5)
NOS2
 Control 1.38 (1.03, 3.77) 1.71 (1.35, 3.59) 0.49 0.99 0.12
 n3 PUFA 1.68 (1.19, 4.62) 2.62 (1.41, 4.28)
NOS3
 Control 23.2 ± 8.26 21.4 ± 4.94 0.56 0.71 0.83
 n3 PUFA 21.7 ± 6.41 21.2 ± 6.58
HAS2
 Control 480 ± 154 538 ± 136 0.35 0.30 0.66
 n3 PUFA 430 ± 147 426 ± 131
1

Values are means ± SDs or medians (IQRs); n = 13 (control) or n = 11 (n3 PUFAs). ADIPOQ, adiponectin; CCL2, chemokine (C-C motif) ligand 2; CD, cluster of differentiation; CRC, Clinical Research Center; HAS2, hyaluronan synthase 2; ICAM1, intercellular adhesion molecule 1; IL6, interleukin 6; NOS2, inducible nitric oxide synthase; NOS3, endothelial nitric oxide synthase; PAI-1, plasminogen activator inhibitor 1; RM-ANOVA, repeated-measures ANOVA; SAA1, serum amyloid A1; TNFα, tumor necrosis factor α.